Application
Figure 1: Western blot analysis using CDH2 mouse mAb against A431 (1), NIH/3T3 (2), Hela (3), C6 (4) and LNCap (5) cell lysate.Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human lung cancer (A), colon cancer (B), ovarian cancer (C) and mammary cancer(D), using CDH2 mouse mAb with DAB staining.Application
Figure 3: Immunofluorescence analysis of A431 cells using CDH2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human Placenta tissues using CDH2 mouse mAbApplication
Figure 4: Flow cytometric analysis of PC-2 cells using CDH2 mouse mAb (green) and negative control (purple).| Product Name | CDH2 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CDHN; NCAD; CD325; CDw325; CDH2 |
| Immunogen | Purified recombinant fragment of human CDH2 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | HumanMouseRat |
| Alternative Names | CDHN NCAD CD325 CDw325 CDH2 |
|---|---|
| Molecular Weight(MW) | 99.8kDa |
| Entrez Gene | 1000 |
|---|
Application
Figure 1: Western blot analysis using CDH2 mouse mAb against A431 (1), NIH/3T3 (2), Hela (3), C6 (4) and LNCap (5) cell lysate.
Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human lung cancer (A), colon cancer (B), ovarian cancer (C) and mammary cancer(D), using CDH2 mouse mAb with DAB staining.
Application
Figure 3: Immunofluorescence analysis of A431 cells using CDH2 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye.
Application
Figure 3: Immunohistochemical analysis of paraffin-embedded human Placenta tissues using CDH2 mouse mAb
Application
Figure 4: Flow cytometric analysis of PC-2 cells using CDH2 mouse mAb (green) and negative control (purple).| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
